Aria Pharmaceuticals, with a valuation of $85 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company has developed an AI-driven drug delivery platform for therapeutic development candidates. The software platform helps in identifying promising hits, derisking the opportunities through preclinical studies, and progressing drug candidates to clinical trials. Aria Pharmaceuticals has already modeled over 300 diseases and has identified 1,000 diseases that it could address. Andrew A. Radin founded Aria Pharmaceuticals in 2014. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $2,510,000. The campaign proceeds will be used for growth and expansion.